[
  {
    "ts": null,
    "headline": "Update: Market Chatter: US House Panel Says Ex-Pfizer Scientist Confirmed Involvement in Delaying COVID-19 Vaccine Results",
    "summary": "(Update with Pfizer's response to a request for comment.) A former Pfizer (PFE) scientist said he",
    "url": "https://finnhub.io/api/news?id=07a2ee256c4672fe7eef975f2fd9f2b1eb55b7d4741568480c319c35720290ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747330376,
      "headline": "Update: Market Chatter: US House Panel Says Ex-Pfizer Scientist Confirmed Involvement in Delaying COVID-19 Vaccine Results",
      "id": 134483761,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Update with Pfizer's response to a request for comment.) A former Pfizer (PFE) scientist said he",
      "url": "https://finnhub.io/api/news?id=07a2ee256c4672fe7eef975f2fd9f2b1eb55b7d4741568480c319c35720290ce"
    }
  },
  {
    "ts": null,
    "headline": "US House panel seeks information from Pfizer over alleged COVID vaccine delay",
    "summary": "U.S. lawmakers onThursday asked Pfizer Inc for information on allegedcomments by a former executive suggesting its researchexecutives intentionally delayed clinical trial results of itsCOVID-19...",
    "url": "https://finnhub.io/api/news?id=347ee9c38805a4dcc98f001794ff2253dd722630cbbaf40bcde0ab4630cce294",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747329368,
      "headline": "US House panel seeks information from Pfizer over alleged COVID vaccine delay",
      "id": 134485420,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "U.S. lawmakers onThursday asked Pfizer Inc for information on allegedcomments by a former executive suggesting its researchexecutives intentionally delayed clinical trial results of itsCOVID-19...",
      "url": "https://finnhub.io/api/news?id=347ee9c38805a4dcc98f001794ff2253dd722630cbbaf40bcde0ab4630cce294"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=6643c202ce5d29b89c001fec914a5dc57108a0944f46bac7b62dfcdbd8c020eb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747327020,
      "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "id": 134489990,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=6643c202ce5d29b89c001fec914a5dc57108a0944f46bac7b62dfcdbd8c020eb"
    }
  },
  {
    "ts": null,
    "headline": "Curevac Receives Additional Positive Validity Decision From European Patent Office In Ongoing Litigation Against Biontech SE",
    "summary": "CureVac NV: * EQS-NEWS: CUREVAC RECEIVES ADDITIONAL POSITIVE VALIDITYDECISIONFROM EUROPEAN PATENT OFFICE IN ONGOING LITIGATION AGAINSTBIONTECH SE * CUREVAC NV - EPO...",
    "url": "https://finnhub.io/api/news?id=65082303d0fb4085a8d9ef3c67fdffd5c867331bf62880faedfe96a5cfa0a690",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747325587,
      "headline": "Curevac Receives Additional Positive Validity Decision From European Patent Office In Ongoing Litigation Against Biontech SE",
      "id": 134484680,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "CureVac NV: * EQS-NEWS: CUREVAC RECEIVES ADDITIONAL POSITIVE VALIDITYDECISIONFROM EUROPEAN PATENT OFFICE IN ONGOING LITIGATION AGAINSTBIONTECH SE * CUREVAC NV - EPO...",
      "url": "https://finnhub.io/api/news?id=65082303d0fb4085a8d9ef3c67fdffd5c867331bf62880faedfe96a5cfa0a690"
    }
  },
  {
    "ts": null,
    "headline": "HHS to stop recommending Covid shots for children, pregnant women, WSJ reports",
    "summary": "The U.S. Department of Health andHuman Services is planning to drop CDC recommendations forroutine Covid-19 vaccines for pregnant women, teens andchildren, the Wall Street Journal reported on...",
    "url": "https://finnhub.io/api/news?id=9cabde1213d0806665201b2f3657ff8c79df5107abd7fde6e50cca0c4c306274",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747325292,
      "headline": "HHS to stop recommending Covid shots for children, pregnant women, WSJ reports",
      "id": 134484582,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "The U.S. Department of Health andHuman Services is planning to drop CDC recommendations forroutine Covid-19 vaccines for pregnant women, teens andchildren, the Wall Street Journal reported on...",
      "url": "https://finnhub.io/api/news?id=9cabde1213d0806665201b2f3657ff8c79df5107abd7fde6e50cca0c4c306274"
    }
  },
  {
    "ts": null,
    "headline": "New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel",
    "summary": "A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations provided by a rival drugmaker.",
    "url": "https://finnhub.io/api/news?id=6bb60ddde94bee66858170e50715c879b60a9cc9cf4ec75995736f547302a5bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747322400,
      "headline": "New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel",
      "id": 134483762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations provided by a rival drugmaker.",
      "url": "https://finnhub.io/api/news?id=6bb60ddde94bee66858170e50715c879b60a9cc9cf4ec75995736f547302a5bc"
    }
  },
  {
    "ts": null,
    "headline": "5 Low Price-to-Book Value Stocks to Buy in May",
    "summary": "The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.",
    "url": "https://finnhub.io/api/news?id=ff29eedc1ff5ffcf2b21a1c7e3eb5355311e0e2dabc3451c63b52529869f2f9a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747312560,
      "headline": "5 Low Price-to-Book Value Stocks to Buy in May",
      "id": 134483763,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.",
      "url": "https://finnhub.io/api/news?id=ff29eedc1ff5ffcf2b21a1c7e3eb5355311e0e2dabc3451c63b52529869f2f9a"
    }
  },
  {
    "ts": null,
    "headline": "FDA delays approval decision for Biohaven rare disease drug",
    "summary": "Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an outside group of advisers to evaluate it as well.",
    "url": "https://finnhub.io/api/news?id=46987ca85db738f7c2eaa5d7d0364d0368504ec81aec46f25e11209fb7ffc90c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747312020,
      "headline": "FDA delays approval decision for Biohaven rare disease drug",
      "id": 134483764,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an outside group of advisers to evaluate it as well.",
      "url": "https://finnhub.io/api/news?id=46987ca85db738f7c2eaa5d7d0364d0368504ec81aec46f25e11209fb7ffc90c"
    }
  },
  {
    "ts": null,
    "headline": "US FDA approves Amneal's self-administered migraine treatment",
    "summary": "The U.S. Food and Drug Administrationhas approved Amneal Pharmaceuticals' self-administeredmigraine drug, giving way to a quick and more convenienttreatment option for patients. The...",
    "url": "https://finnhub.io/api/news?id=814f4be6b225b766ef964d2e6f462f086375e7ee41ff85619345935948bf39a6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747303308,
      "headline": "US FDA approves Amneal's self-administered migraine treatment",
      "id": 134467641,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "The U.S. Food and Drug Administrationhas approved Amneal Pharmaceuticals' self-administeredmigraine drug, giving way to a quick and more convenienttreatment option for patients. The...",
      "url": "https://finnhub.io/api/news?id=814f4be6b225b766ef964d2e6f462f086375e7ee41ff85619345935948bf39a6"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Harvesting Portfolio Week 219: $21,900 Allocated, $2,206.52 In Projected Dividends",
    "summary": "Expect market gains in late 2025 as CPI trends lower. See how strategic dividend reinvesting drives income growth and diversification for long-term success.",
    "url": "https://finnhub.io/api/news?id=674f07c8bb3980794b7356d798cd932b7d28558a1eb290d554136fc396c04e29",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747299600,
      "headline": "Dividend Harvesting Portfolio Week 219: $21,900 Allocated, $2,206.52 In Projected Dividends",
      "id": 134467157,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810162/image_1445810162.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Expect market gains in late 2025 as CPI trends lower. See how strategic dividend reinvesting drives income growth and diversification for long-term success.",
      "url": "https://finnhub.io/api/news?id=674f07c8bb3980794b7356d798cd932b7d28558a1eb290d554136fc396c04e29"
    }
  }
]